Conference - Arlington, Virginia, U.S.A.
Top pharmaceutical, biotech, and regulatory representatives will discuss the current complexities and controversies in pharmacovigilance and risk management throughout all phases of development and marketed use, new and updated legislation in various ICH regions, important new harmonization initiatives, life cycle management, the impact of social media, biosimilars, and the use of other data sources and observational research.This program will focus primarily on drug products and biologics.
Learning Objectives:
At the conclusion of this meeting, participants should be able to:
• Describe the latest regulatory framework for pharmacovigilance in the US, Europe, and Japan
• Discuss new safety harmonization initiatives
• Describe best practices for improving risk management and life cycle management approaches
• Discuss how companies are using social media to investigate safety information in the context of regulatory obligations
• Explain how to use other data sources and observational research for effective safety analysis
Monday, January 23, 2012 to Wednesday, January 25, 2012
Sheraton National Hotel Arlington, Arlington, Virginia, U.S.A.
Contact : Drug Information Association (www.diahome.org)
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
